PMID- 21378157 OWN - NLM STAT- MEDLINE DCOM- 20110930 LR - 20220318 IS - 1460-2385 (Electronic) IS - 0931-0509 (Print) IS - 0931-0509 (Linking) VI - 26 IP - 6 DP - 2011 Jun TI - Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats. PG - 1785-96 LID - 10.1093/ndt/gfr035 [doi] AB - BACKGROUND: Renal calcium oxalate (CaOx) crystal deposition is associated with epithelial injury and movement of inflammatory cells into the interstitium. We have proposed that oxalate (Ox)- and CaOx crystal-induced injury is most likely caused by reactive oxygen species (ROS) produced by activation of membrane nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. METHODS: Present study was undertaken to determine the effect of NADPH oxidase inhibitor apocynin on the expression of kidney injury molecule-1 (KIM-1) and renal CaOx crystal deposition in rats with hyperoxaluria. We also investigated the urinary excretion of KIM-1, osteopontin (OPN) and monocyte chemoattractant protein-1 (MCP-1) and renal expression of OPN and ED-1. Male Sprague-Dawley rats were fed a diet containing 5% hydroxyl-L-proline (HLP) and 4 mmol apocynin to drink for 28 days. Urine was collected on Days 7, 14, 21 and 28. After that, rats were sacrificed and their kidneys processed for various microscopic and molecular investigations. RESULTS: HLP consumption produced heavy deposits of CaOx crystals. Renal expression of KIM-1 and OPN and urinary excretion of KIM-1, OPN, H(2)O(2) and MCP-1 was significantly increased. ED-1-positive cells migrated into renal interstitium. Apocynin treatment caused significant reduction of crystal deposits, injured and dilated tubules; renal expression of KIM-1, OPN and ED-1 and urinary excretion of KIM-1, OPN, MCP-1 and H(2)O(2). Apocynin had no effect on the urinary excretion of Ox. CONCLUSIONS: This is the first study of urinary excretion and renal expression of KIM-1 in association with renal CaOx crystal deposition, experimental or clinical. The results indicate that NADPH oxidase inhibition leads to reduction in KIM-1 expression and urinary excretion as well as renal CaOx crystal deposition. KIM-1 is an important marker of renal epithelial injury. The results provide further support to our proposal that renal epithelial injury is critical for crystal retention and that injury is in part caused by the production of ROS with the involvement of NADPH oxidase. FAU - Zuo, Jian AU - Zuo J AD - Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA. FAU - Khan, Aslam AU - Khan A FAU - Glenton, Patricia A AU - Glenton PA FAU - Khan, Saeed R AU - Khan SR LA - eng GR - R01 DK078602/DK/NIDDK NIH HHS/United States GR - R01-DK078602/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20110304 PL - England TA - Nephrol Dial Transplant JT - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association JID - 8706402 RN - 0 (Cell Adhesion Molecules) RN - 0 (Chemokine CCL2) RN - 0 (Havcr1protein, rat) RN - 0 (Oxalates) RN - 0 (Reactive Oxygen Species) RN - 106441-73-0 (Osteopontin) RN - 2612HC57YE (Calcium Oxalate) RN - EC 1.6.3.- (NADPH Oxidases) RN - RMB44WO89X (Hydroxyproline) SB - IM CIN - Nephrol Dial Transplant. 2011 Jun;26(6):1759-61. PMID: 21551084 MH - Animals MH - Blotting, Western MH - Calcium Oxalate/*metabolism MH - Cell Adhesion Molecules/*metabolism MH - Chemokine CCL2/metabolism MH - Hydroxyproline/*toxicity MH - Hyperoxaluria/*chemically induced/*metabolism MH - Immunoenzyme Techniques MH - Kidney/cytology/drug effects/*metabolism MH - Male MH - NADPH Oxidases/*antagonists & inhibitors/metabolism MH - Osteopontin/metabolism MH - Oxalates/pharmacology MH - Oxidative Stress MH - Rats MH - Rats, Sprague-Dawley MH - Reactive Oxygen Species/metabolism PMC - PMC3145402 EDAT- 2011/03/08 06:00 MHDA- 2011/10/01 06:00 PMCR- 2012/06/01 CRDT- 2011/03/08 06:00 PHST- 2011/03/08 06:00 [entrez] PHST- 2011/03/08 06:00 [pubmed] PHST- 2011/10/01 06:00 [medline] PHST- 2012/06/01 00:00 [pmc-release] AID - gfr035 [pii] AID - 10.1093/ndt/gfr035 [doi] PST - ppublish SO - Nephrol Dial Transplant. 2011 Jun;26(6):1785-96. doi: 10.1093/ndt/gfr035. Epub 2011 Mar 4.